Stryker | SYK - Operating Expenses


Stryker reported $4.8B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Abbott USD 11.66B 1.2B Sep/2026
AtriCure USD 150.1M 6.16M Sep/2026
Baxter International USD 6.5B 3.82B Sep/2026
Becton, Dickinson and Co. USD 4.16B 20.25B Sep/2026
Boston Scientific USD 4.13B 72M Sep/2026
CONMED USD 298.41M 8.67M Sep/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Danaher USD 53.62B 1.04B Sep/2026
Dexcom USD 990.1M 53.5M Jun/2026
Edwards Lifesciences USD 10.86B 9.64B Sep/2026
Globus Medical USD 585.49M 250.09M Sep/2026
Haemonetics USD 145.79M 448K Sep/2026
Insulet USD 652.2M 19.8M Sep/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
Intuitive Surgical USD 2B 86.5M Sep/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Olympus JPY 210.33B 58.09B Jun/2026
Smith & Nephew USD 2.59B 71M Jun/2026
Steris USD 1.27B 62.5M Sep/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 286.06M 17.71M Sep/2026
Teleflex USD 3.49B 589.18M Sep/2026
Terumo JPY 222.33B 46.54B Jun/2026
Zimmer Biomet Holdings USD 1.72B 110.9M Sep/2026